In an integrated audit of internal control over financial reporting and the financial statements, the auditor also may use this work to obtain evidence supporting the auditor's assessment of control risk for purposes of the audit of the financial statements.
A new development in uveitis treatment during the past few years is the increased use of tumor necrosis alpha (TNF-Î±) inhibitors, specifically infliximab (Remicade, Janssen Biotech Inc.) and adalimumab (Humira, Abbott Laboratories).
Uveitis is inflammation in the uvea, which includes the iris, choroid, and the ciliary body in the eye. It can also affect nearby parts of the eye, like the retina, vitreous, and optic nerve. (See eye diagram below.) Sometimes uveitis is caused by bacteria or a virus in the eye.